Lee Ainslie's REGN Position Overview
Lee Ainslie (via Maverick Capital LTD) currently holds 1,824 shares of Regeneron Pharmaceuticals, Inc. (REGN) worth $1.38 M, representing 0.01% of the portfolio. First purchased in 2020-Q3, this short-term holding has been held for 7 quarters.
Based on 13F filings, Lee Ainslie has maintained this position in REGN for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2026, adding 1,824 shares. Largest reduction occurred in Q1 2024, reducing 1,758 shares.
Analysis based on 13F filings available since 2013 Q2
Lee Ainslie's Regeneron Pharmaceuticals (REGN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Regeneron Pharmaceuticals (REGN) Trades by Lee Ainslie
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2026 | +1,824 | New Buy | 1,824 | $758.27 |
| Q1 2024 | -1,758 | Sold Out | 0 | $0.00 |
| Q4 2023 | +1,758 | New Buy | 1,758 | $878.29 |
| Q4 2021 | -490 | Sold Out | 0 | $0.00 |
| Q3 2021 | +490 | New Buy | 490 | $606.12 |
| Q4 2020 | -588 | Sold Out | 0 | $0.00 |
| Q3 2020 | +588 | New Buy | 588 | $559.52 |
Lee Ainslie's Regeneron Pharmaceuticals Investment FAQs
Lee Ainslie first purchased Regeneron Pharmaceuticals, Inc. (REGN) in Q3 2020, acquiring 588 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Lee Ainslie has held Regeneron Pharmaceuticals, Inc. (REGN) for 7 quarters since Q3 2020.
Lee Ainslie's largest addition to Regeneron Pharmaceuticals, Inc. (REGN) was in Q3 2026, adding 1,824 shares worth $1.38 M.
According to the latest 13F filing for Q3 2026, Lee Ainslie's firm, Maverick Capital LTD, owns 1,824 shares of Regeneron Pharmaceuticals, Inc. (REGN), valued at approximately $1.38 M.
As of the Q3 2026 filing, Regeneron Pharmaceuticals, Inc. (REGN) represents approximately 0.01% of Lee Ainslie's publicly disclosed stock portfolio, making it one of their key holdings.
Lee Ainslie's peak holding in Regeneron Pharmaceuticals, Inc. (REGN) was 1,824 shares, as reported at the end of Q3 2026.